about
Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expressionLocalization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancerMolecular cloning, purification and in situ localization of human colon kallikreinTwenty Years of PSA: From Prostate Antigen to Tumor MarkerA novel protease homolog differentially expressed in breast and ovarian cancerThe new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulationAlternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell linesThe diagnostic and prognostic utility of prostate-specific antigen for diseases of the breast.Biochemical composition of human saliva in relation to other mucosal fluids.Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.Prostate kallikrein markers in diagnosis, risk stratification and prognosis.The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Genetic architecture of early pre-inflammatory stage transcription signatures of autoimmune diabetes in the pancreatic lymph nodes of the NOD mouse reveals significant gene enrichment on chromosomes 6 and 7.Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model buildingThe promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretionsImmunology and immunotherapy approaches for prostate cancer.The autolytic regulation of human kallikrein-related peptidase 6.Usefulness of Total PSA Value in Prostate Diseases Diagnosis.Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA).A molecular clock based on the expansion of gene families.The epigenetic basis for the aberrant expression of kallikreins in human cancers.Prostate-specific antigen: molecular forms and the human kallikrein gene family.Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids.Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.Gene Expression Profile of Prostate Cancer Patients by Chemiluminescent Analysis
P2860
Q22009031-3F99CC4B-4241-4687-AA62-0AFEABAA00D5Q22010477-D9E7F646-63E8-4EDB-B289-4446A24C9919Q24290170-A5E2733D-21F2-4BD9-B7FF-639E60782D60Q24290337-49F8729E-BD66-4609-A785-41B06791C1A0Q24528242-E0C7304F-824C-4F14-952E-AD55D8A8E6C6Q24564782-F3EC2C93-2B80-4CD5-B522-2724408E489FQ24654651-F90B9C3F-2FA4-4BA1-83FD-861D7397DC01Q28118219-2C205362-6FAB-435B-828B-18CAB9C40204Q28215890-BB098B69-EF3E-472C-A86B-D8BB94779B48Q33884420-98AFB7FE-2317-4FAB-B8D3-98A135B501FFQ34294679-6CE30EC8-59D5-4D48-B865-BAF548117DC3Q34446230-959031A3-BB27-4A0A-858E-437F5040B588Q34447102-AE6D8FF7-9389-4D54-A074-3FC8A511C101Q35683035-5937D876-2366-49E9-A633-B947485BE85FQ35861497-BE401D7B-9620-4AD7-BBA1-1434DEB01270Q36251923-BB6B1F11-9F7C-4F50-BB1A-8DF8FD151DD0Q36279827-32CC78EA-B666-41A2-8D26-4DB55E9D8D59Q36619043-04FCADE4-C27B-4C7B-B7FE-B807E41C0298Q36621078-BE903992-D9FC-4F12-B9B2-448F98E90265Q36786512-048155C8-7112-4F6A-8D5E-5560C107337AQ36840687-6E414842-40B3-445D-9DD1-B134AF1D9FF5Q37104224-07584E38-AE33-4D30-8748-14A900E602E6Q39678142-7447CF65-FF4F-493B-97F7-728522A5C096Q39715756-56B4EB16-655F-41F9-89AF-282458AB3B5BQ40262748-FF31EC82-ABA5-4C7E-BEE2-857DBCDF30CEQ41409455-61C45978-7DA1-40FB-8223-08E1381018A2Q42993405-D83E8E36-646C-4E7B-9F8A-30E664F019A7Q52054063-CD1211C3-0C46-475F-9C88-4C2E13F683E7Q58129611-F529E953-CD4D-4815-AF41-D2865B39D377
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Characterization of the human kallikrein locus.
@ast
Characterization of the human kallikrein locus.
@en
type
label
Characterization of the human kallikrein locus.
@ast
Characterization of the human kallikrein locus.
@en
prefLabel
Characterization of the human kallikrein locus.
@ast
Characterization of the human kallikrein locus.
@en
P2093
P1433
P1476
Characterization of the human kallikrein locus.
@en
P2093
Cleutjens CB
Riegman PH
Suurmeijer L
Vlietstra RJ
P356
10.1016/S0888-7543(05)80275-7
P577
1992-09-01T00:00:00Z